Abbott R J, Loizou L A
Br J Psychiatry. 1986 Jan;148:47-51. doi: 10.1192/bjp.148.1.47.
The neuroleptic malignant syndrome (NMS) occurs as a hypersensitivity response in certain patients exposed to neuroleptics. It is a relatively rare, but potentially lethal complication, the incidence of which may have been underestimated. Recent interest in NMS has arisen due to the recognition that specific therapy may now be available. This review summarises the clinical features and discusses recent ideas regarding aetiology and treatment.
神经阻滞剂恶性综合征（NMS）发生于某些使用神经阻滞剂的患者，是一种超敏反应。它是一种相对罕见但可能致命的并发症，其发病率可能被低估了。由于认识到现在可能有特定的治疗方法，最近人们对NMS产生了兴趣。本综述总结了其临床特征，并讨论了有关病因和治疗的最新观点。
